Weight loss drug could reduce heart attack risk by 20%, study finds - The Guardian
- Weight loss drug could reduce heart attack risk by 20%, study finds The Guardian
- Millions of Brits 'should get Ozempic to slash their chances of heart attack and stroke': Major study hails slimming jabs as biggest breakthrough since statins because drugs cut risk even in patients who don't lose weight Daily Mail
- Weight loss jabs like Ozempic cuts risk of heart attack and stroke, study claims The Independent
- What the papers say – May 14 Evening Standard
- Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial Nature.com